CNS Response, Inc. (CNSO.OB) Awarded Third U.S. Patent Targeting the Development of New Indications for Existing Drugs
CNS Response, Inc. announced that it has received a patent from the U.S. Patent and Trademark Office. The patent, numbered…
CNS Response, Inc. announced that it has received a patent from the U.S. Patent and Trademark Office. The patent, numbered…
Brainstorm Cell Therapeutics Inc. today announced the election of Malcolm S. Taub to its Board of Directors. Malcolm Taub has…
China Agritech, Inc., a national liquid and granular organic compound fertilizer manufacturer and distributor in China, announced that Mr. Yu…
MDRNA, Inc. announced today that it has entered into a licensing agreement with Novartis for MDRNA's liposomal technology platform for…
Today, Axial Vector Energy Corporation announced that it has planned April 4th, 2009 as the date to formally transfer technology…
Kraig Biocraft Laboratories, Inc. announced this morning that Dr. Fraser’s team has "made significant progress on developing enzymes and strategies…
The market Kraig Biocraft Laboratories has targeted is generally referred to as the "technical textiles" market. This market encompasses a…
MMR Information Systems Inc. (previously Favrille Inc.) operates through its subsidiary, MyMedicalRecords Inc. (MMR), to provide consumer-controlled Personal Health Records…
Cord Blood America, Inc., in support of its stated goal to become the most respected stem cell preservation company in…
In the last couple of years, much focus has been made about rising energy costs. The fluctuations in the price…